The global Proteomics Market, by application, has been segmented into drug discovery, clinical diagnosis, clinical proteomics and others. The clinical diagnosis segment is expected to hold the largest market share owing to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases drug development. The drug discovery segment is anticipated to grow at the fastest CAGR owing to continuous search for alternative efficient methods to deliver enhanced drugs and increased RD investments by pharmaceutical biotechnology companies.